secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001193125-24-057906
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam announces departure of EVP, Chief Legal Officer Indrani Franchini
-------------------------------------------------------------------------

- Separation effective March 1, 2024; severance of $597,000 (12 months' base salary) paid bi-weekly.
- Lump sum payment for 2023 annual incentive plan bonus, adjusted by corporate multiplier determined by Board.
- One-year consulting arrangement through March 2025; continued vesting of unvested equity awards during consulting period.
- $500/hour compensation for consulting beyond 10 hours per month; up to $15,000 legal fee reimbursement.
- Consulting period; outstanding stock options remain exercisable for 3 months after consulting period; non-compete restrictions waived.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000119312524057906/0001193125-24-057906-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000119312524057906/d746189d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-057906

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer